Knockdown of pseudogene derived from lncRNA DUXAP10 inhibits cell proliferation, migration, invasion, and promotes apoptosis in pancreatic cancer
- 5 January 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 119 (4) , 3671-3682
Abstract
Current evidence suggests that pseudogene derived lncRNAs may be important players in human cancer progression. Our previous study showed that DUXAP10 could promote cell proliferation in colorectal cancer. However, the clinical significance and potential role of DUXAP10 in human pancreatic cancer (PC) has not been uncovered. In this study, we found that DUXAP10 was overexpressed in PC tissues compared with normal tissues. DUXAP10 expression was significantly higher in patients with an advanced TNM stage and positive lymph node metastasis. Bioinformatic analysis showed that cell cycle progression was increased in patients with high DUXAP10 expression. In vitro and in vivo assays of DUXAP10 alterations revealed a complex integrated phenotype affecting cell growth, apoptosis, migration, and invasion. Mechanistic studies revealed that DUXAP10 has a crucial role in G2/M arrest. We further showed that DUXAP10 regulated PC cell proliferation through interact with RNA‐binding protein EZH2 and LSD1. Overall, our findings indicates that DUXAP10 is an oncogenic lncRNA that promotes PC proliferation and metastasis.Keywords
Funding Information
- National Natural Science Foundation of China (81300834, 31470947)
This publication has 35 references indexed in Scilit:
- KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic CancerCancers, 2017
- Fast or slow?Nature Reviews Cancer, 2016
- Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?Gut, 2016
- Pancreatic cancerThe Lancet, 2016
- The emerging role of lncRNAs in cancerNature Medicine, 2015
- Basic biology and therapeutic implications of lncRNAAdvanced Drug Delivery Reviews, 2015
- Pancreatic AdenocarcinomaNew England Journal of Medicine, 2014
- The lncRNA-MYC regulatory network in cancerTumor Biology, 2014
- Recent progress in pancreatic cancerCA: A Cancer Journal for Clinicians, 2013
- MDM2 Inhibitors for Pancreatic Cancer TherapyMini-Reviews in Medicinal Chemistry, 2010